403 related articles for article (PubMed ID: 26858376)
1. Vaccine Assistance To Low- And Middle-Income Countries Increased To $3.6 Billion In 2014.
Haakenstad A; Birger M; Singh L; Liu P; Lim S; Ng M; Dieleman JL
Health Aff (Millwood); 2016 Feb; 35(2):242-9. PubMed ID: 26858376
[TBL] [Abstract][Full Text] [Related]
2. Costs of vaccine programs across 94 low- and middle-income countries.
Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
[TBL] [Abstract][Full Text] [Related]
3. Estimating total spending by source of funding on routine and supplementary immunisation activities in low-income and middle-income countries, 2000-17: a financial modelling study.
Ikilezi G; Micah AE; Bachmeier SD; Cogswell IE; Maddison ER; Stutzman HN; Tsakalos G; Brenzel L; Dieleman JL
Lancet; 2021 Nov; 398(10314):1875-1893. PubMed ID: 34742369
[TBL] [Abstract][Full Text] [Related]
4. Gavi's Transition Policy: Moving From Development Assistance To Domestic Financing Of Immunization Programs.
Kallenberg J; Mok W; Newman R; Nguyen A; Ryckman T; Saxenian H; Wilson P
Health Aff (Millwood); 2016 Feb; 35(2):250-8. PubMed ID: 26858377
[TBL] [Abstract][Full Text] [Related]
5. Effect of donor funding for immunization from Gavi and other development assistance channels on vaccine coverage: Evidence from 120 low and middle income recipient countries.
Ikilezi G; Augusto OJ; Dieleman JL; Sherr K; Lim SS
Vaccine; 2020 Jan; 38(3):588-596. PubMed ID: 31679863
[TBL] [Abstract][Full Text] [Related]
6. Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050.
Global Burden of Disease 2020 Health Financing Collaborator Network
Lancet; 2021 Oct; 398(10308):1317-1343. PubMed ID: 34562388
[TBL] [Abstract][Full Text] [Related]
7. Tracking donor funding towards achieving the Global Vaccine Action Plan (GVAP) goals: A landscape analysis (1990-2016).
Ikilezi G; Zlavog B; Augusto OJ; Sherr K; Lim SS; Dieleman JL
Vaccine; 2018 Nov; 36(49):7487-7495. PubMed ID: 30366804
[TBL] [Abstract][Full Text] [Related]
8. What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?
Brenzel L
Vaccine; 2015 May; 33 Suppl 1():A93-8. PubMed ID: 25919183
[TBL] [Abstract][Full Text] [Related]
9. Monitoring what governments "give for" and "spend on" vaccine procurement: Vaccine Procurement Assistance and Vaccine Procurement Baseline.
Nelson EA; Bloom DE; Mahoney RT
PLoS One; 2014; 9(2):e89593. PubMed ID: 24586899
[TBL] [Abstract][Full Text] [Related]
10. Innovative financing instruments for global health 2002-15: a systematic analysis.
Atun R; Silva S; Knaul FM
Lancet Glob Health; 2017 Jul; 5(7):e720-e726. PubMed ID: 28619230
[TBL] [Abstract][Full Text] [Related]
11. Why The Decade Of Vaccines?
Health Aff (Millwood); 2016 Feb; 35(2):188-9. PubMed ID: 26858368
[TBL] [Abstract][Full Text] [Related]
12. Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe.
Blau J; Hoestlandt C; D Clark A; Baxter L; Felix Garcia AG; Mounaud B; Mosina L
Vaccine; 2015 May; 33 Suppl 1():A34-9. PubMed ID: 25919171
[TBL] [Abstract][Full Text] [Related]
13. GAVI funding meeting exceeds expectations.
Usher AD
Lancet; 2011 Jun; 377(9784):2165-6. PubMed ID: 21714163
[No Abstract] [Full Text] [Related]
14. Sources and Focus of Health Development Assistance, 1990-2014.
Dieleman JL; Graves C; Johnson E; Templin T; Birger M; Hamavid H; Freeman M; Leach-Kemon K; Singh L; Haakenstad A; Murray CJ
JAMA; 2015 Jun; 313(23):2359-68. PubMed ID: 26080340
[TBL] [Abstract][Full Text] [Related]
15. Financing of global health: tracking development assistance for health from 1990 to 2007.
Ravishankar N; Gubbins P; Cooley RJ; Leach-Kemon K; Michaud CM; Jamison DT; Murray CJ
Lancet; 2009 Jun; 373(9681):2113-24. PubMed ID: 19541038
[TBL] [Abstract][Full Text] [Related]
16. Challenges for nationwide vaccine delivery in African countries.
Songane M
Int J Health Econ Manag; 2018 Jun; 18(2):197-219. PubMed ID: 29047019
[TBL] [Abstract][Full Text] [Related]
17. Estimates of aid for reproductive, maternal, newborn, and child health: findings from application of the Muskoka2 method, 2002-17.
Dingle A; Schäferhoff M; Borghi J; Lewis Sabin M; Arregoces L; Martinez-Alvarez M; Pitt C
Lancet Glob Health; 2020 Mar; 8(3):e374-e386. PubMed ID: 32035034
[TBL] [Abstract][Full Text] [Related]
18. Development assistance for health: past trends, associations, and the future of international financial flows for health.
Dieleman JL; Schneider MT; Haakenstad A; Singh L; Sadat N; Birger M; Reynolds A; Templin T; Hamavid H; Chapin A; Murray CJ
Lancet; 2016 Jun; 387(10037):2536-44. PubMed ID: 27086170
[TBL] [Abstract][Full Text] [Related]
19. Perceptions of the usefulness of external support to immunization coverage in Chad: an analysis of the GAVI-Alliance cash-based support.
Ferrinho P; Dramé M; Tumusiime P
Pan Afr Med J; 2013; 15():44. PubMed ID: 24106572
[TBL] [Abstract][Full Text] [Related]
20. Sustainability of National Immunization Programme (NIP) performance and financing following Global Alliance for Vaccines and Immunization (GAVI) support to the Democratic Republic of the Congo (DRC).
Le Gargasson JB; Breugelmans JG; Mibulumukini B; Da Silva A; Colombini A
Vaccine; 2013 Apr; 31(15):1886-91. PubMed ID: 23462529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
